The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Simon Fisher
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Baotou, China
- Research Site
Beijing, China
- Research Site
Benxi, China
- Research Site
Changchun, China
- Research Site
Chengdu, China
- Research Site
Chongqing, China
- Research Site
Dalian, China
- Research Site
Dongguan, China
- Research Site
Foshan, China
- Research Site
Fuzhou, China
- Research Site
Guangzhou, China
- Research Site
Guiyang, China
- Research Site
Haikou, China
- Research Site
Hangzhou, China
- Research Site
Hhht, China
- Research Site
Hubei, China
- Research Site
Jimo, China
- Research Site
Jinan, China
- Research Site
Kunming, China
- Research Site
Linyi, China
- Research Site
Nanjing, China
- Research Site
Nantong, China
- Research Site
Qingdao, China
- Research Site
Shanghai, China
- Research Site
Shantou, China
- Research Site
Shenyang, China
- Research Site
Shiyan, China
- Research Site
Suzhou, China
- Research Site
Taiyuan, China
- Research Site
Tianjin, China
- Research Site
Wenzhou, China
- Research Site
Wuhan, China
- Research Site
Wuxi, China
- Research Site
Xi'an, China
- Research Site
Zhanjiang, China
- Research Site
Zhengzhou, China
- Research Site
Ürümqi, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2012
- Primary completion
- 31 May 2014
- Completion
- 31 May 2014
- Last update posted
- 2 Feb 2016
- Registered enrollment
- 2,165
- Registry id
- NCT01608724
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.